Valuation : DexCom, Inc.

Market Cap 34.27B 29.53B 27.69B 25.28B 47.62B 3,276B 47.77B 329B 128B 1,653B 129B 126B 5,483B P/E 2026 *
36.4x
P/E 2027 * 30.6x
Enterprise Value 33.51B 28.88B 27.07B 24.71B 46.56B 3,203B 46.71B 321B 125B 1,617B 126B 123B 5,361B EV / Sales 2026 *
6.41x
EV / Sales 2027 * 5.73x
Free-Float
91.27%
Yield 2026 *
-
Yield 2027 * -
1 day+1.71%
1 week-1.65%
Current month+8.83%
1 month+21.84%
3 months+23.16%
6 months+23.10%
Current year+36.84%
1 week 87.51
Extreme 87.51
91.14
1 month 82.09
Extreme 82.09
92.59
Current year 56.72
Extreme 56.72
92.59
1 year 54.11
Extreme 54.11
92.59
3 years 54.11
Extreme 54.11
142
5 years 54.11
Extreme 54.11
164.86
10 years 10.66
Extreme 10.655
164.86
Manager TitleAgeSince
Chief Executive Officer 47 01/01/2026
Director of Finance/CFO 46 19/03/2021
Chief Tech/Sci/R&D Officer - 01/05/2024
Director TitleAgeSince
Chairman 68 30/07/2018
Director/Board Member 67 20/11/2009
Director/Board Member 47 01/01/2026
Date Insider Type Main position Quantity % Market Cap.
27/08/26 Sell

Head of Human Resources

-2,565 0.0007%
22/08/26 Tax

General Counsel

-1,451 0.0004%
22/08/26 Tax

Chief Financial Officer

-1,451 0.0004%
Change 5-day change 1-year change 3-year change Capi.($)
+1.71%-1.65%+20.55%-12.18% 34.27B
+0.79%-3.58%-15.22%+7.72% 195B
+1.40%-2.27%-1.70%+10.84% 117B
+0.25%+1.25%+10.43%+80.01% 61.45B
+0.74%-1.29%-1.79%-32.39% 51.62B
+0.80%-1.18%+27.69%+52.27% 51.03B
+1.82%+2.98% - - 30.95B
-2.49%-4.42%+36.66%-17.51% 23.75B
-0.91%-3.06%-6.22%+14.03% 23.41B
+0.35%-1.74%-4.60%+0.77% 22.79B
Average +0.32%-1.39%+7.31%+11.51% 61.07B
Weighted average by Cap. +0.50%-1.95%+0.22%+14.13%

Financials

2026 *2027 *
Net sales 5.23B 4.51B 4.23B 3.86B 7.27B 500B 7.29B 50.13B 19.56B 252B 19.64B 19.21B 837B 5.8B 5B 4.69B 4.28B 8.06B 554B 8.08B 55.59B 21.69B 280B 21.78B 21.3B 928B
Net income 974M 840M 787M 719M 1.35B 93.12B 1.36B 9.34B 3.64B 47.01B 3.66B 3.58B 156B 1.15B 990M 928M 847M 1.6B 110B 1.6B 11.01B 4.3B 55.43B 4.31B 4.22B 184B
Net Debt -761M -656M -615M -561M -1.06B -72.75B -1.06B -7.3B -2.85B -36.72B -2.86B -2.8B -122B -1.06B -915M -858M -783M -1.47B -101B -1.48B -10.17B -3.97B -51.21B -3.99B -3.9B -170B
Logo DexCom, Inc.
DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 71.5% of net sales.
Employees
11,050
Date Price Change Volume
28/08/26 $90.82 +1.71% 2,546,957
27/08/26 $89.29 +0.37% 3,026,636
26/08/26 $88.96 -0.22% 3,822,845
25/08/26 $89.16 -2.09% 4,105,930
24/08/26 $91.06 -1.39% 4,451,431
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
28
Last Close Price
90.82USD
Average target price
94.12USD
Spread / Average Target
+3.63%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. DXCM Stock